- LDS
- /Medical Tests
- /Oncomine™ Dx Express™ Test for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring
Diseases (3)Access to Oncomine™ Dx Express™ Test for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring is restricted.
OverviewAccess to Oncomine™ Dx Express™ Test for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring is restricted.
Clinical UtilityAccess to Oncomine™ Dx Express™ Test for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring is restricted.
InterpretationAccess to Oncomine™ Dx Express™ Test for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring is restricted.
Reference RangesAccess to Oncomine™ Dx Express™ Test for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring is restricted.
MethodologyAccess to Oncomine™ Dx Express™ Test for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring is restricted.
Turnaround TimeAccess to Oncomine™ Dx Express™ Test for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring is restricted.
CPTAccess to Oncomine™ Dx Express™ Test for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring is restricted.
LOINCAccess to Oncomine™ Dx Express™ Test for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring is restricted.
ICD10Access to Oncomine™ Dx Express™ Test for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring is restricted.
Additional ICD10Access to Oncomine™ Dx Express™ Test for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring is restricted.
ReferencesAccess to Oncomine™ Dx Express™ Test for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring is restricted.